Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide

Name: Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

This Summary describes the key points of the evaluation, while the Science evaluation of Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide provides detailed technical information on the human health, environmental and value assessments of fluazaindolizine and Salibro Nematicide.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-03-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide (French, HTML) HTML
Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide (English, HTML) HTML

Related open data

Health Canada